Middle-of-the-road vehicle.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to J Kosterlitz.
Explore the source record for details and available documents.
Jittery players in the health care reform debate have signed up a multitude of lawyers, lobbyists, political consultants, pollsters and public relations experts. And the real action hasn't even started.
Explore the source record for details and available documents.
Many economists have fingered technology as a major culprit in spiraling health care costs. But who should decide whether new medical devices and procedures are cost-effective?
Explore the source record for details and available documents.
"Integrated" health plans, which tie together doctors, hospitals and other services, are being touted as a remedy for the nation's ailing health system. But in Minnesota, where such plans are relatively well established, a side effect has appeared: a rash of mergers and acquisitions that could undermine competition in the health care market.
In the view of some critics, Donna E. Shalala is a bleeding-heart liberal, turned loose in the biggest domestic federal agency. But the new Health and Human Services Secretary has a strong pragmatic streak. And the President seems to have hired her less as an architect of social policy than as a general contractor.
Health care reform poses a classic litmus test on the role of government. Will President Clinton lean toward free-market principles, or will he take a more-activist approach? Here's a guide to decoding the philosophical subtext of the plan that he's set to unveil soon.
Explore the source record for details and available documents.
Elderly Americans would take a direct hit under President Clinton's economic plan. So why aren't they screaming? Maybe they hope Clinton will make it up to them in his health reform proposal. For political reasons, he'd probably like to. For budgetary reasons, he probably can't.
Explore the source record for details and available documents.
Prescription drug prices in the United States are some of the highest in the world, and U.S. trade officials and the American pharmaceutical industry are doing something about it. They're pressing for trade agreements that could raise drug prices in other countries.
Explore the source record for details and available documents.
Most policy experts assume that the public will have to make sacrifices if the health care system is overhauled. The public assumes nothing of the kind. The upshot could be a major political backlash against Bill Clinton and Congress.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Nearly 12 years after the epidemic began, AIDS activists and public health officials think they finally have a commander in chief who will wage an all-out war against the disease. Are expectations running too high?